MedEdTalks Ophthalmology is a continuing medical education podcast for physicians to allow them to learn while on the go and obtain CME credits. This show will focus in on ophthalmology topics, such as nAMD and Diabetic Retinopathy and includes interviews with Dr. Rishi Singh from the Cole Eye Insti…
In this podcast, expert clinicians will discuss new efficacy, safety, and durability data on dosing regimens, delivery systems, and emerging therapies for the treatment of neovascular age-related macular degeneration (nAMD). https://www.healio.com/cme/mededtalks/ophthalmology/20240729/2-the-retina-radar-with-dr-arshad-khanani-namd-management-in-2024
In this podcast, expert clinicians will discuss ongoing clinical trials and the latest data regarding advances in vitreoretinal care. https://www.healio.com/cme/mededtalks/ophthalmology/20240729/1-the-retina-radar-with-dr-arshad-khanani-clinical-trials-at-the-summit-2024
In this podcast, expert clinicians will answer your questions about thyroid eye disease. https://cme.healio.com/mededtalks/ophthalmology/20240405/3-thyroid-eye-disease-your-questions-answered
In this podcast, expert clinicians will discuss treatment approaches and monitoring parameters for thyroid eye disease. https://cme.healio.com/mededtalks/ophthalmology/20240405/2-thyroid-eye-disease-treatment-and-monitoring
In this podcast, expert clinicians will discuss the screening and diagnosis of thyroid eye disease. https://cme.healio.com/mededtalks/ophthalmology/20240405/1-thyroid-eye-disease-screening-and-diagnosis
In this podcast, expert clinicians will review the current and emerging gene therapies for IRDs, as well as advances in drug delivery in this setting.
In this podcast, expert clinicians will discuss best practices for genetic testing and counseling for patients with IRDs, including interprofessional approaches and collaboration.
In this podcast, expert clinicians will discuss current guidelines for clinical assessment of IRDs and the importance of interprofessional collaborative care.
In this podcast, expert clinicians will discuss new research on the disease state, clinical trial designs, and emerging therapies that hold potential in the treatment of TED.
In this podcast, expert clinicians will discuss surgical procedures that can improve outcomes for patients with TED.
In this podcast, expert clinicians will discuss the benefit/risk profile of insulin-like growth factor-I receptor (IGF-1R) therapy in the treatment of TED.
In this podcast, expert clinicians will discuss real-world evidence regarding the safety and efficacy of current medical treatments for TED.
In this podcast, expert clinicians will discuss advanced techniques and technology for guiding refractive surgery to reduce complications and achieve better visual outcomes.
In this podcast, expert clinicians will discuss advances in presurgical/surgical diagnostics and intraoperative guidance systems and their impact on improved refractive outcomes.
In this podcast, expert clinicians will discuss new evidence and real-world studies regarding the management of diabetic macular edema.
In this podcast, expert clinicians will discuss advances in biometry and IOL platforms.
In this podcast, expert clinicians will discuss the latest information on phacoemulsification, including the use of fluidics, ultrasound, phacodynamics, advanced techniques, and instrumentation.
In this podcast, expert clinicians will discuss the management of geographic atrophy (GA) secondary to age-related macular degeneration (AMD).
In this podcast, expert clinicians will discuss surgical techniques in cataract removal.
In this podcast, expert clinicians with discuss the latest information on the digital integration of medical and surgical eye care.
In this podcast, expert faculty will discuss gene therapy for vitreoretinal diseases.
In this podcast, expert clinicians will discuss ongoing clinical trials and the latest data in vitreoretinal care from the Clinical Trials Summit.
In this podcast, expert faculty will discuss the management of diabetic retinopathy (DR).
In this podcast, expert faculty will discuss the management of nAMD.
In this podcast, expert clinicians will discuss long-acting injectables in RVO management.
In this podcast, expert clinicians will discuss long-acting injectables in DME management.
In this podcast, expert clinicians will discuss long-acting injectables in nAMD management.
In this educational activity, faculty discuss current and emerging strategies for diagnosis and management of meibomian gland dysfunction and associated conditions.
In this educational activity, faculty discuss recent developments in ocular surface disease presented at the Fall 2022 academic conferences.
In this podcast, expert clinicians will discuss current and future approaches for the management of patients with uveitis.
In this podcast, expert clinicians will discuss the utilization of surgery in the management of patients with retinal diseases.
In this podcast, expert clinicians will discuss the utilization of imaging in patients with retinal diseases.
In this podcast, expert clinicians will discuss current and future approaches for the management of patients with retinal vein occlusion.
In this podcast, expert clinicians will discuss current and future approaches for the management of patients with neovascular age-related macular degeneration, dry age-related macular degeneration, and geographic atrophy.
In this podcast, expert clinicians will discuss current and future approaches for the management of patients with diabetic eye disease.
The angiopoietin/Tie2 pathway is an attractive therapeutic target for the management of retinal and choroidal vascular diseases, as it has been identified to play a role in vascular permeability and angiogenesis within the eye. Several therapies targeting this pathway have been investigated, and the FDA recently approved the first agent that inhibits both the angiopoietin-2 (Ang-2) and vascular endothelial growth factor (VEGF)-A pathways for the treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME). Dual inhibition of these 2 pathways has the potential to enhance visual acuity outcomes while lowering the treatment burden. In this podcast, Dr. Carl Regillo and Dr. Nancy Holekamp discuss the efficacy and safety of therapies targeting Ang-2 in DME.
The angiopoietin/Tie2 pathway is an attractive therapeutic target for the management of retinal and choroidal vascular diseases, as it has been identified to play a role in vascular permeability and angiogenesis within the eye. Several therapies targeting this pathway have been investigated, and the FDA recently approved the first agent that inhibits both the angiopoietin-2 (Ang-2) and vascular endothelial growth factor (VEGF)-A pathways for the treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME). Dual inhibition of these 2 pathways has the potential to enhance visual acuity outcomes while lowering the treatment burden. In this podcast, Dr. Carl Regillo and Dr. Arshad Khanani discuss the efficacy and safety of therapies targeting Ang-2 in nAMD.
The angiopoietin/Tie2 pathway is an attractive therapeutic target for the management of retinal and choroidal vascular diseases, as it has been identified to play a role in vascular permeability and angiogenesis within the eye. Several therapies targeting this pathway have been investigated, and the FDA recently approved the first agent that inhibits both the angiopoietin-2 (Ang-2) and vascular endothelial growth factor (VEGF)-A pathways for the treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME). Dual inhibition of these 2 pathways has the potential to enhance visual acuity outcomes while lowering the treatment burden. In this podcast, Dr. Carl Regillo and Dr. Judy Kim discuss the Tie2 pathway and its role in the pathophysiology of retinal vascular diseases.
Steven Ferrucci, OD, provides an overview of the CE-certified ePublication, Retinal Disease Digest: Opportunities for Optometrists Volume 1, Issue 4.
Rishi P. Singh, MD, provides an overview of the CE-certified ePublication, Retinal Disease Digest: Opportunities for Optometrists Volume 1, Issue 3.
Steven Ferrucci, OD, provides an overview of the CE-certified ePublication, Retinal Disease Digest: Opportunities for Optometrists Volume 1, Issue 2.
Rishi P. Singh, MD, provides an overview of the CE-certified ePublication, Retinal Disease Digest: Opportunities for Optometrists Volume 1, Issue 1.
In this podcast, expert clinicians will discuss best practices for reducing ocular toxicities in myeloma patients through the multidisciplinary team.
In this podcast, expert clinicians will discuss strategies to mitigate and manage ocular toxicities related to multiple myeloma therapy.
In this podcast, expert clinicians will discuss the frequency and identification of ocular toxicities of patients on myeloma therapy.
In this podcast, expert clinicians will discuss the mechanisms behind ocular toxicities that have been associated with antibody drug conjugates used for cancer treatment.
This educational activity will review best practices regarding the use of gel stents in the treatment of glaucoma.
In this podcast, John Samples, MD, and Brian Francis, MD, discuss the current and evolving role of optical coherence tomography angiography in the management of glaucoma.
In this podcast, John Samples, MD, and Michael Giovigno, MD, review best practices for the use of cyclophotocoagulation in the management of glaucoma.
In this podcast, John R. Samples, MD, and Russell Swan, MD, discuss the relevance of cerebrospinal fluid pressure in the management of glaucoma.
© 2020-2025 Ivy Podcast Discovery LLC
